The cash and stock acquisition of Juno was announced in June 2015 and closed earlier this month.
Celgene’s new debt issue comes in four parts:
The notes will be issued Tuesday. Celgene intends to use net proceeds from the offering to finance a portion of the Juno acquisition and to pay fees and expenses associated with the offering.
Citigroup Global Markets, Deutsche Bank Securities, J.P. Morgan Securities, Merrill Lynch and Pierce, Fenner & Smith will act as joint book-runners. A banker associated with the deal said that he expects it to be fully subscribed, mostly by institutional investors.